NOBILIS HEALTH CORP. – Trademark Portfolio
Entity Type: 03
NOBILIS HEALTH CORP. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 15 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NORTHSTAR HEALTHCARE. The owner is based in HOUSTON, TX.
4120 SOUTHWEST FREEWAY, SUITE 150
HOUSTON, TX 77027
Showing of trademarks Trademarks
Trademark Classifications
NOBILIS HEALTH CORP.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NOBILIS HEALTH CORP. have?
NOBILIS HEALTH CORP. has 16 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 12 cancelled.
What trademark classes does NOBILIS HEALTH CORP. file in?
NOBILIS HEALTH CORP. files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are NOBILIS HEALTH CORP.'s most well-known trademarks?
NOBILIS HEALTH CORP.'s registered trademark portfolio includes well-known marks such as NORTHSTAR HEALTHCARE. These are among 1 currently registered trademark in the portfolio.
What is NOBILIS HEALTH CORP.'s trademark registration success rate?
NOBILIS HEALTH CORP. has a 6% trademark registration rate, with 1 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.